Rapid subcutaneous immunoglobulin administration every second week results in high and stable serum immunoglobulin G levels in patients with primary antibody deficiencies.

Source:http://linkedlifedata.com/resource/pubmed/id/18341618

Download in:

View as

General Info

PMID
18341618